Therapeutic Asset Ratings
1,531 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
SOLUBLE FLUORESCEIN
Hepatocellular Carcinoma
Mayo Clinic
N/A
D
(30)
SOLUBLE FLUORESCEIN
Malignant Pancreatic Neoplasm
Mayo Clinic
N/A
D
(30)
SOMATOSTATIN
Post-Operative Gastrointestinal Anastomotic Dehiscence, Non-Human Animal
Tongji Hospital
N/A
D
(30)
SOMATOSTATIN
Glucose Metabolism Disease
Rigshospitalet, Denmark
N/A
D
(30)
SOMATOSTATIN
Metabolic Dysfunction-Associated Steatotic Liver Disease
Rigshospitalet, Denmark
N/A
D
(30)
SOMATOSTATIN
Rectal Carcinoma
Tongji Hospital
N/A
D
(30)
SOMATROPIN RECOMBINANT
Disorder Of Fatty Acid And Ketone Body Metabolism
University of Aarhus
N/A
D
(30)
SOYBEAN OIL
Metabolic Dysfunction-Associated Steatotic Liver Disease
Ohio State University
N/A
D
(30)
SOYBEAN OIL
Obesity Disorder
Ohio State University
N/A
D
(30)
Spironolactone
Chronic Kidney Disease
Institute of Liver and Biliary Sciences, India
N/A
D
(30)
Spironolactone
Metabolic Dysfunction-Associated Steatotic Liver Disease
Institute of Liver and Biliary Sciences, India
N/A
D
(30)
Steviol Glycosides
Obesity Disorder
Midwest Center for Metabolic and Cardiovascular Research
N/A
D
(30)
Steviol Glycosides
Type 2 Diabetes Mellitus
Midwest Center for Metabolic and Cardiovascular Research
N/A
D
(30)
SUBSTANCE P
Migraine Disorder
Danish Headache Center
N/A
D
(30)
SUFENTANYL
Obesity Disorder
IVO JURISIC
N/A
D
(30)
Sulfadiazine
Breast Carcinoma
OHSU Knight Cancer Institute
N/A
D
(30)
Sulfadiazine
Head And Neck Carcinoma
OHSU Knight Cancer Institute
N/A
D
(30)
Sulfadiazine
Radiodermatitis
OHSU Knight Cancer Institute
N/A
D
(30)
Sulfasalazine
Cirrhosis Of Liver
The Second Affiliated Hospital of Chongqing Medical University
N/A
D
(30)
Sulfasalazine
Fibrotic Liver Disease
The Second Affiliated Hospital of Chongqing Medical University
N/A
D
(30)
Sulfur hexafluoride
Portal Hypertension
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
N/A
D
(30)
Sulpegfilgrastim
Neutropenia
The First Affiliated Hospital of Soochow University
N/A
D
(30)
Sulperazon
Biliary Atresia
Children's Hospital of Fudan University
N/A
D
(30)
Sulperazon
Cholangitis
Children's Hospital of Fudan University
N/A
D
(30)
sy001
Secondary Malignant Neoplasm
Cell Origin Biotech (Hangzhou) Co., Ltd.
N/A
D
(30)
Showing 1101 to 1125 of 1,531 assets
Previous
Page 45 of 62
Next